Thought Leader Liaison Director - Hematology

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. We are currently seeking a dynamic, motivated, and experienced individual for the position of Thought Leader Liaison Director – Hematology (Enzomenib). This field-based role will focus on shaping the external thought leader ecosystem and pre-launch readiness for enzomenib, while also supporting the eventual transition to an in-market commercial role. The TLL will engage hematology thought leaders across academic centers and leading community institutions, generate insights to inform launch planning and strategy, and ensure continuity of engagement and impact through commercialization. Essential Functions Required for Job: Develop and execute a pre-launch thought leader engagement plan for enzomenib, including identification, profiling, and prioritization of key hematology/oncology experts and emerging voices. Map the thought leader landscape, influence pathways, and treatment ecosystem to inform launch targeting, segmentation, and engagement strategy Build and strengthen relationships with thought leaders in acute leukemia and related hematologic malignancies, aligning engagement with development and launch milestones Capture and synthesize external insights on unmet need, treatment patterns, diagnostic considerations, and adoption barriers, translating findings into actionable launch strategy implications Partner cross-functionally to shape advisory board strategy and ensure meaningful, compliant insight generation Provide field perspective and external feedback to refine pre-launch narrative, messaging, and engagement approaches Serve as thought leader engagement lead within the cross-functional launch team, integrating insights into launch readiness plans Coordinate planning for key congress engagements and scientific meetings in partnership with internal stakeholders Educate internal teams on the evolving hematology landscape and thought leader ecosystem ahead of launch Ensure all engagement and insight generation activities are compliant and appropriate for a pre-launch activity Support transition from pre-launch to commercialization, maintaining continuity of thought leader relationships and aligning engagement with evolving brand priorities. Drive post-launch thought leader engagement and insight generation to inform adoption, advocacy development, and ongoing lifecycle strategy. Knowledge, Skills and Abilities (general & technical): Excellent communication skills with strong credibility among hematology/oncology clinical leaders. Strong knowledge of acute leukemia and hematologic malignancy treatment landscape. Strategic mindset with ability to translate insights into business impact. Advanced cross-functional collaboration and leadership skills. High standards of compliance and sound judgment. Strong organizational awareness and ability to operate in a matrixed environment. Education and Experience Requirements: Bachelor’s degree required; advanced degree in life sciences or healthcare strongly preferred Minimum 10 years of relevant experience in the biotechnology or pharmaceutical industry Prior Thought Leader Liaison (TLL) in Hematology strongly preferred, including experience engaging leukemia or hematologic malignancy experts Deep understanding of the hematology landscape, including acute leukemia treatment paradigms, academic centers, and key opinion leader networks Demonstrated success engaging KOLs and translating insights into actionable commercial strategies Experience supporting pre-launch or launch of a hematology/oncology asset strongly preferred Travel Requirements: Willingness to travel extensively (50–70%). Mental/Physical Requirements: Extensive travel: Regular travel throughout assigned territory—estimated 60–80% of working time—requiring long periods on the road and flexible scheduling.  Overnight stays as part of business travel may be required depending on the territory. Mobility & stamina: Frequent in-person visits to physician offices, clinics, hospitals, and trade shows, requiring sustained driving, walking, standing, and sitting. Independent, field-based work: Ability to manage one’s schedule, work autonomously, and adapt to variable meeting locales (conference rooms, doctors’ offices, hotel spaces) This is an individual contributor role and does not have direct reports or formal people ‑management responsibilities. The base salary range for this role is $199,500.00 - $249,400.00 Base salary is part of our total rewards package which also includes the opportunity for merit-based salary increases, short incentive plan participation, eligibility for our 401(k) plan, medical, dental, vision, life and disability insurances and leaves provided in line with your work state.  Our robust time-off policy includes flexible paid time off, 11 paid holidays plus additional time off for a shut-down period during the last week of December, 80 hours of paid sick time upon hire and each year thereafter.  Total compensation, including base salary to be offered, will depend on elements unique to each candidate, including candidate experience, skills, education and other factors permitted by law. Disclaimer: The above statements are intended to describe the general nature and level of work being performed by people assigned to this classification. They are not to be construed as an exhaustive list of all responsibilities, duties, and skills required of personn